Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
M&A / Property Routine +

Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California

Cannabix Breath Test Gains Traction in US Manufacturing Sector Following Commercial Launch

By The Northwire Desk — AI Analysis Apr 20, 2026 · 08:45 BLO · 0.73 Cannabix Technologies Inc.
Executive Summary
  • Omega Laboratories will present the Cannabix Marijuana Breath Test (MBT) at the 2026 NDASA Conference in California (April 26–29, 2026).
  • Presentation focuses on technical advancements and ability to detect recent THC consumption via breath.
  • Method development and validation work for MBT is complete; technology is being integrated into Omega's laboratory services.
  • MBT detects delta-9 THC in breath within 4 hours of consumption at concentrations above 5 picograms per liter (pg/L).
  • CEO Rav Mlait emphasizes the need for practical solutions measuring recent use as cannabis legalization expands.
Material Impact
  • Incremental Validation: The news confirms the completion of method development and validation work previously announced in March 2026. It does not introduce new revenue contracts or financial metrics.
  • Partnership Confirmation: Reinforces the strategic partnership with Omega Laboratories, a critical component for commercializing the MBT system (lab analysis).
  • Market Education: Participation at NDASA is a marketing and educational initiative rather than a direct sales milestone. The market impact is likely muted compared to the March Commercial Launch announcement.
  • Expectation Alignment: This news aligns with the trajectory set by the March 16 Commercial Launch and April 1 Virginia client delivery. It does not exceed expectations materially but confirms execution of the rollout plan.
  • Risk Mitigation: Validates that the technology is ready for integration, reducing technical risk associated with the product launch phase.
BLO · Price
Company Overview
  • Company: Cannabix Technologies Inc., a Canadian-based technology company focused on breath analysis for drug and alcohol screening.
  • Flagship Project 1 (MBT): Marijuana Breath Test system designed to detect recent cannabis use in workplace environments using non-invasive breath collection units (BCU) and proprietary cartridges analyzed by Omega Laboratories.
  • Flagship Project 2 (BreathLogix): Alcohol screening devices for safety-critical industries (maritime, mining, oil & gas), featuring facial recognition and cloud connectivity.
  • Development Status: MBT has passed FCC emissions testing, peer-reviewed validation published in Journal of Analytical Toxicology, and commercial rollout initiated with first deliveries to construction and manufacturing clients. BreathLogix has international distributor orders in Australia and Europe.
Read the original news release →

More from Cannabix Technologies Inc.

Jun 29, 2026 · 08:45

Cannabix scales its breath-based THC and alcohol screening hardware into global mining and industrial sectors, but revenue remains negligible against operating burn.

Production / Operations Jun 15, 2026 · 08:45

Cannabix Technologies Inc.

M&A / Property May 29, 2026 · 08:45

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Production / Operations May 13, 2026 · 08:45

Cannabix Secures UL/CSA Certs, Clears Path for Gov Tenders Amidst Steady Commercial Rollout

Regulatory May 04, 2026 · 08:45

Cannabix Executes Commercial Rollout Amidst Dilution Concerns

Production / Operations Apr 01, 2026 · 08:45

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client

Production / Operations